{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:58:33Z","timestamp":1795042713850,"version":"4.10.2"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100013598","name":"American Acne and Rosacea Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013598","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Almirall and Ortho Dermatologics"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-72788-9","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T09:03:31Z","timestamp":1779181411000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Dual site targeting of the bacterial 70S ribosome by tetracyclines"],"prefix":"10.1038","volume":"17","author":[{"given":"Swapnil C.","family":"Devarkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6528-5068","authenticated-orcid":false,"given":"Ivan B.","family":"Lomakin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4504-8038","authenticated-orcid":false,"given":"Jimin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Grada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4011-8308","authenticated-orcid":false,"given":"Christopher G.","family":"Bunick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"72788_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1749-6632.1948.tb27262.x","volume":"51","author":"BM Duggar","year":"1948","unstructured":"Duggar, B. M. Aureomycin; a product of the continuing search for new antibiotics. Ann. N. Y Acad. Sci. 51, 177\u2013181 (1948).","journal-title":"Ann. N. Y Acad. Sci."},{"key":"72788_CR2","doi-asserted-by":"publisher","first-page":"a025387","DOI":"10.1101\/cshperspect.a025387","volume":"6","author":"TH Grossman","year":"2016","unstructured":"Grossman, T. H. Tetracycline antibiotics and resistance. Cold Spring Harb. Perspect. Med 6, a025387 (2016).","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"72788_CR3","first-page":"1031","volume":"20","author":"HE Baldwin","year":"2021","unstructured":"Baldwin, H. E. & Ward, D. B. Jr Fifty years of minocycline and its evolution: a dermatological perspective. J. Drugs Dermatol 20, 1031\u20131036 (2021).","journal-title":"J. Drugs Dermatol"},{"key":"72788_CR4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/00007691-198206000-00001","volume":"4","author":"BA Cunha","year":"1982","unstructured":"Cunha, B. A., Sibley, C. M. & Ristuccia, A. M. Doxycycline. Ther. Drug Monit. 4, 115\u2013135 (1982).","journal-title":"Ther. Drug Monit."},{"key":"72788_CR5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s40265-019-1053-4","volume":"79","author":"ED Deeks","year":"2019","unstructured":"Deeks, E. D. Sarecycline: first global approval. Drugs 79, 325\u2013329 (2019).","journal-title":"Drugs"},{"key":"72788_CR6","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1007\/s10096-019-03590-3","volume":"38","author":"YR Lee","year":"2019","unstructured":"Lee, Y. R. & Burton, C. E. Eravacycline, a newly approved fluorocycline. Eur. J. Clin. Microbiol Infect. Dis. 38, 1787\u20131794 (2019).","journal-title":"Eur. J. Clin. Microbiol Infect. Dis."},{"key":"72788_CR7","doi-asserted-by":"crossref","unstructured":"Brodersen, D. E. et al. The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit. Cell 103, 1143\u20131154 (2000).","DOI":"10.1016\/S0092-8674(00)00216-6"},{"key":"72788_CR8","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1073\/pnas.1216691110","volume":"110","author":"L Jenner","year":"2013","unstructured":"Jenner, L. et al. Structural basis for potent inhibitory activity of the antibiotic tigecycline during protein synthesis. Proc. Natl. Acad. Sci. USA 110, 3812\u20133816 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"72788_CR9","doi-asserted-by":"publisher","first-page":"8188","DOI":"10.1073\/pnas.1605127113","volume":"113","author":"AI Cocozaki","year":"2016","unstructured":"Cocozaki, A. I. et al. Resistance mutations generate divergent antibiotic susceptibility profiles against translation inhibitors. Proc. Natl. Acad. Sci. USA 113, 8188\u20138193 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"72788_CR10","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/s41594-023-01047-y","volume":"30","author":"H Paternoga","year":"2023","unstructured":"Paternoga, H. et al. Structural conservation of antibiotic interaction with ribosomes. Nat. Struct. Mol. Biol. 30, 1380\u20131392 (2023).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"72788_CR11","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01031-21","volume":"12","author":"Z Zhang","year":"2021","unstructured":"Zhang, Z., Morgan, C. E., Bonomo, R. A. & Yu, E. W. Cryo-EM determination of eravacycline-bound structures of the ribosome and the multidrug efflux pump AdeJ of acinetobacter baumannii. mBio 12, e0103121 (2021).","journal-title":"mBio"},{"key":"72788_CR12","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1093\/nar\/gkad103","volume":"51","author":"IB Lomakin","year":"2023","unstructured":"Lomakin, I. B., Devarkar, S. C., Patel, S., Grada, A. & Bunick, C. G. Sarecycline inhibits protein translation in Cutibacterium acnes 70S ribosome using a two-site mechanism. Nucleic Acids Res. 51, 2915\u20132930 (2023).","journal-title":"Nucleic Acids Res"},{"key":"72788_CR13","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/s41589-020-0578-x","volume":"16","author":"IA Osterman","year":"2020","unstructured":"Osterman, I. A. et al. Tetracenomycin X inhibits translation by binding within the ribosomal exit tunnel. Nat. Chem. Biol. 16, 1071\u20131077 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"72788_CR14","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/s41589-023-01343-0","volume":"19","author":"EC Leroy","year":"2023","unstructured":"Leroy, E. C., Perry, T. N., Renault, T. T. & Innis, C. A. Tetracenomycin X sequesters peptidyl-tRNA during translation of QK motifs. Nat. Chem. Biol. 19, 1091\u20131096 (2023).","journal-title":"Nat. Chem. Biol."},{"key":"72788_CR15","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/jac\/dkl224","volume":"58","author":"KN Agwuh","year":"2006","unstructured":"Agwuh, K. N. MacGowan A. Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines. J. Antimicrob. Chemother. 58, 256\u2013265 (2006).","journal-title":"J. Antimicrob. Chemother."},{"key":"72788_CR16","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1007\/s10096-012-1680-0","volume":"31","author":"BA Cunha","year":"2012","unstructured":"Cunha, B. A. Oral doxycycline for non-systemic urinary tract infections (UTIs) due to P. aeruginosa and other Gram negative uropathogens. Eur. J. Clin. Microbiol Infect. Dis. 31, 2865\u20132868 (2012).","journal-title":"Eur. J. Clin. Microbiol Infect. Dis."},{"key":"72788_CR17","first-page":"1705","volume":"36","author":"G Campistron","year":"1986","unstructured":"Campistron, G. et al. Pharmacokinetics and bioavailability of doxycycline in humans. Arzneimittelforschung 36, 1705\u20131707 (1986).","journal-title":"Arzneimittelforschung"},{"key":"72788_CR18","first-page":"76","volume":"30","author":"AS Malmborg","year":"1984","unstructured":"Malmborg, A. S. Bioavailability of doxycycline monohydrate. a comparison with equivalent doses of doxycycline hydrochloride. Chemotherapy 30, 76\u201380 (1984).","journal-title":"Chemotherapy"},{"key":"72788_CR19","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s40257-020-00523-1","volume":"21","author":"J Paik","year":"2020","unstructured":"Paik, J. Topical minocycline foam 4%: a review in acne vulgaris. Am. J. Clin. Dermatol 21, 449\u2013456 (2020).","journal-title":"Am. J. Clin. Dermatol"},{"key":"72788_CR20","doi-asserted-by":"publisher","first-page":"20530","DOI":"10.1073\/pnas.2008671117","volume":"117","author":"Z Batool","year":"2020","unstructured":"Batool, Z., Lomakin, I. B., Polikanov, Y. S. & Bunick, C. G. Sarecycline interferes with tRNA accommodation and tethers mRNA to the 70S ribosome. Proc. Natl. Acad. Sci. USA 117, 20530\u201320537 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"72788_CR21","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.molcel.2008.02.026","volume":"30","author":"N Vazquez-Laslop","year":"2008","unstructured":"Vazquez-Laslop, N., Thum, C. & Mankin, A. S. Molecular mechanism of drug-dependent ribosome stalling. Mol. Cell 30, 190\u2013202 (2008).","journal-title":"Mol. Cell"},{"key":"72788_CR22","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1093\/nar\/gkaa001","volume":"48","author":"AE d\u2019Aquino","year":"2020","unstructured":"d' Aquino, A.E. et al. Mutational characterization and mapping of the 70S ribosome active site. Nucleic Acids Res. 48, 2777\u20132789 (2020).","journal-title":"Nucleic Acids Res"},{"key":"72788_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31906-z","volume":"13","author":"M Ahn","year":"2022","unstructured":"Ahn, M. et al. Modulating co-translational protein folding by rational design and ribosome engineering. Nat. Commun. 13, 4243 (2022).","journal-title":"Nat. Commun."},{"key":"72788_CR24","doi-asserted-by":"publisher","first-page":"5798","DOI":"10.1093\/nar\/gkw493","volume":"44","author":"MG Lawrence","year":"2016","unstructured":"Lawrence, M. G. et al. The extended loops of ribosomal proteins uL4 and uL22 of Escherichia coli contribute to ribosome assembly and protein translation. Nucleic Acids Res. 44, 5798\u20135810 (2016).","journal-title":"Nucleic Acids Res"},{"key":"72788_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/nmicrobiol.2016.265","volume":"2","author":"K Denks","year":"2017","unstructured":"Denks, K. et al. The signal recognition particle contacts uL23 and scans substrate translation inside the ribosomal tunnel. Nat. Microbiol 2, 16265 (2017).","journal-title":"Nat. Microbiol"},{"key":"72788_CR26","doi-asserted-by":"publisher","first-page":"15379","DOI":"10.1073\/pnas.1410356111","volume":"111","author":"AR Davis","year":"2014","unstructured":"Davis, A. R., Gohara, D. W. & Yap, M. N. Sequence selectivity of macrolide-induced translational attenuation. Proc. Natl. Acad. Sci. USA 111, 15379\u201315384 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"72788_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-64692-5","volume":"16","author":"EA Syroegin","year":"2025","unstructured":"Syroegin, E.A. et al. Structural insights into context-specific inhibition of bacterial translation by macrolides. Nat. Commun. 16, 9685 (2025).","journal-title":"Nat. Commun."},{"key":"72788_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115878","volume":"44","author":"CL Ekemezie","year":"2025","unstructured":"Ekemezie, C.L. et al. Extensive natural variation in bacterial ribosomal drug-binding sites. Cell Rep. 44, 115878 (2025).","journal-title":"Cell Rep."},{"key":"72788_CR29","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.celrep.2018.08.093","volume":"25","author":"CM Kurylo","year":"2018","unstructured":"Kurylo, C. M. et al. Endogenous rRNA sequence variation can regulate stress response gene expression and phenotype. Cell Rep. 25, 236\u2013248 e236 (2018).","journal-title":"Cell Rep."},{"key":"72788_CR30","doi-asserted-by":"publisher","first-page":"12150","DOI":"10.1073\/pnas.1613055113","volume":"113","author":"J Marks","year":"2016","unstructured":"Marks, J. et al. Context-specific inhibition of translation by ribosomal antibiotics targeting the peptidyl transferase center. Proc. Natl. Acad. Sci. USA 113, 12150\u201312155 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"72788_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49797-7","volume":"15","author":"X Li","year":"2024","unstructured":"Li, X. et al. Structural basis for differential inhibition of eukaryotic ribosomes by tigecycline. Nat. Commun. 15, 5481 (2024).","journal-title":"Nat. Commun."},{"key":"72788_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59388-9","volume":"16","author":"Q Shao","year":"2025","unstructured":"Shao, Q. et al. T cell toxicity induced by tigecycline binding to the mitochondrial ribosome. Nat. Commun. 16, 4080 (2025).","journal-title":"Nat. Commun."},{"key":"72788_CR33","unstructured":"Outpatient Antibiotic Prescriptions \u2014 United States, (eds) (2022)."},{"key":"72788_CR34","doi-asserted-by":"publisher","first-page":"17158","DOI":"10.1073\/pnas.1008685107","volume":"107","author":"D Bulkley","year":"2010","unstructured":"Bulkley, D., Innis, C. A., Blaha, G. & Steitz, T. A. Revisiting the structures of several antibiotics bound to the bacterial ribosome. Proc. Natl. Acad. Sci. USA 107, 17158\u201317163 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"72788_CR35","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1016\/j.jid.2024.07.013","volume":"144","author":"IB Lomakin","year":"2024","unstructured":"Lomakin, I. B., Devarkar, S. C., Grada, A. & Bunick, C. G. Mechanistic Basis for the Translation Inhibition of Cutibacterium acnes by Clindamycin. J. Invest Dermatol 144, 2553\u20132561 e2553 (2024).","journal-title":"J. Invest Dermatol"},{"key":"72788_CR36","doi-asserted-by":"crossref","unstructured":"Stuart, W. S. et al. Cryo-EM reveals multiple mechanisms of ribosome inhibition by doxycycline. bioRxiv, 2025.2011.2008.686982 (2025).","DOI":"10.1101\/2025.11.08.686982"},{"key":"72788_CR37","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jsb.2005.07.007","volume":"152","author":"DN Mastronarde","year":"2005","unstructured":"Mastronarde, D. N. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 152, 36\u201351 (2005).","journal-title":"J. Struct. Biol."},{"key":"72788_CR38","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"72788_CR39","doi-asserted-by":"crossref","unstructured":"Watson Z. L. et al. Structure of the bacterial ribosome at 2 A resolution. Elife 9, e60482 (2020).","DOI":"10.7554\/eLife.60482"},{"key":"72788_CR40","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. Sect. D., Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. Sect. D., Biol. Crystallogr."},{"key":"72788_CR41","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. Sect. D., Biol. Crystallogr. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. Sect. D., Biol. Crystallogr."},{"key":"72788_CR42","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput Chem."},{"key":"72788_CR43","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen, E. F. et al. UCSF ChimeraX: Structure visualization for researchers, educators, and developers. Protein Sci. 30, 70\u201382 (2021).","journal-title":"Protein Sci."},{"key":"72788_CR44","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1107\/S0907444910045749","volume":"67","author":"MD Winn","year":"2011","unstructured":"Winn, M. D. et al. Overview of the CCP4 suite and current developments. Acta Crystallogr D. Biol. Crystallogr 67, 235\u2013242 (2011).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"72788_CR45","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera - A visualization system for exploratory research and analysis. J. Comput Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput Chem."},{"key":"72788_CR46","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1002\/pro.3198","volume":"26","author":"J Wang","year":"2017","unstructured":"Wang, J. Experimental charge density from electron microscopic maps. Protein Sci. 26, 1619\u20131626 (2017).","journal-title":"Protein Sci."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72788-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72788-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72788-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T09:03:36Z","timestamp":1779181416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72788-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["72788"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-72788-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CGB has served as an investigator and\/or consultant for Almirall, Ortho Dermatologics, Sun\u00a0Pharma, and Teladoc. AG is former Head of R&D and Medical Affairs at Almirall US. AG serves as an Associate Editor for the Journal of Investigative Dermatology, an Associate Editor for the International Journal of Dermatology, a Physician Editor for VisualDx, a member of the Board of Directors for the Biology of Skin Foundation, and a Senior\u00a0Medical Director at AbbVie,\u00a0all outside this\u00a0work. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4452"}}